scispace - formally typeset
I

Imke Metz

Researcher at University of Göttingen

Publications -  81
Citations -  4415

Imke Metz is an academic researcher from University of Göttingen. The author has contributed to research in topics: Multiple sclerosis & Natalizumab. The author has an hindex of 31, co-authored 75 publications receiving 3552 citations.

Papers
More filters
Journal ArticleDOI

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

TL;DR: This study provides an overview of the clinical and paraclinical features of NMOSD in Caucasians and demonstrates a number of distinct disease characteristics in seropositive and seronegative patients.
Journal ArticleDOI

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

TL;DR: Although lesion size >5 cm was associated with a slightly higher EDSS at last follow-up, long-term prognosis in patients with disease duration >10 years was better compared with a population-based multiple sclerosis cohort matched for disease duration (EDSS 3.5; P < 0.001).
Journal ArticleDOI

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

TL;DR: Antibodies to MOG can be found in a distinct subgroup of adult patients with clinically definite multiple sclerosis with a specific clinical phenotype and may indicate disease heterogeneity.
Journal ArticleDOI

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons

TL;DR: The data demonstrate that the occurrence of microglial nodules is not specific to MS and is associated with degenerating as well as damaged axons in early MS, and show that early MS microglia/macrophages exhibit both pro- and antiinflammatory phenotypes.